[Renal excretion of methotrexate in an in vivo model in minipigs]

J Cermanová1, J Chládek, L Sispera

  • 1Ustav farmakologie, Univerzita Karlova v Praze, Lékarská fakulta v Hradci Králové. cermanovaj@lfhk.cuni.cz

Acta Medica (Hradec Kralove). Supplementum
|June 21, 2001
PubMed

Insights

The minipig model effectively mimics human renal excretion of high-dose methotrexate (HDMTX), showing clearance is influenced by urine pH and glomerular filtration. This supports its use in preclinical drug development.

Area of Science:

  • Pharmacology
  • Nephrology
  • Preclinical Research

Context:

  • High-dose methotrexate (HDMTX) is primarily renally excreted in humans.
  • Understanding the mechanisms of renal excretion is crucial for optimizing HDMTX therapy and preventing toxicity.
  • The minipig model offers a potential human-like preclinical platform for studying drug disposition.

Purpose:

  • To evaluate the suitability of the minipig model for preclinical assessment of renal excretion of HDMTX.
  • To investigate the relationship between methotrexate clearance, glomerular filtration, and urine pH in minipigs.
  • To determine the correlation between renal and extrarenal clearance of methotrexate.

Summary:

  • Methotrexate (MTX) is renally excreted via glomerular filtration and active tubular transport.
  • In minipigs, renal clearance of MTX was significantly higher than inulin clearance (a marker for glomerular filtration).
  • Significant correlations were observed between MTX clearance and urine pH, as well as glomerular filtration rate.
  • MTX renal clearance ranged from 1.36 to 3.2 ml/min/kg across different urine pH levels.
  • A strong relationship was found between renal and extrarenal MTX clearance.

Impact:

  • The minipig model demonstrates high fidelity in replicating human-like renal excretion of HDMTX.
  • Findings highlight the critical role of urine pH and glomerular filtration in modulating MTX renal clearance.
  • This study validates the minipig as a valuable preclinical tool for investigating MTX pharmacokinetics and informing clinical strategies.

Related Concept Videos